Osprey (ASX:OSP) share price rises on distribution agreement

The Osprey share price is currently trading higher as the company announced a distribution agreement. We take a closer look at the news.

| More on:
piggy bank next to big red heart representing osprey share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Osprey Medical Inc (ASX: OSP) share price is on the move today as the company announced a deal with Regional Health Care Group to distribute Osprey products. At the time of writing, the Osprey share price is trading 4.17% higher at 2.5 cents.

What Osprey does

Osprey Medical aims to make heart imaging procedures safer for patients with poor kidney function. The company's core technologies originated from research conducted by Dr David Kaye at Melbourne's Baker Institute.

Its proprietary dye reduction and monitoring technologies are designed to help physicians minimise dye usage and monitor the dose levels of dye in real time throughout the procedure, potentially saving lives and money in the process.

Distribution agreement

This morning, the Osprey share price has shot up as the company announced a new distribution agreement. Osprey announced an agreement with Australian owned medical distribution company, Regional Health Care Group (RHCG). The deal will see RHCG exclusively distribute Osprey's products across Australia and New Zealand.

The three year deal will result in Osprey's technology being made available to healthcare professionals across both Australia and New Zealand for the first time. Furthermore, the contract has annual minimum sales volumes and a fixed transfer price over the term of the agreement providing sales security for Osprey.

This agreement complements the company's strategic alliance with GE Healthcare which provides exclusive distribution of Osprey's product portfolio.

Osprey's President and CEO, Mike McCormick, said of the deal:

We are excited to enter this agreement with RHCG which will see the Australian developed technology coming to the Australian and New Zealand markets. Our technology originates from Australia and it has been a long-held desire to offer it to Australian healthcare professionals. This agreement is the first step in addressing the rising issue of CI-AKI as a result of heart imaging procedures in patients with CKD.

An alarming 25% of patients having heart procedures are at risk of having a CI-AKI event, which is sudden damage to the kidneys caused by the x-ray imaging dye. CI-AKI frequently leads to negative patient outcomes, longer hospital stays and, in some cases, kidney failure and death.

What now for the Osprey share price?

The Osprey share price has been on a steady decline since the initial announcement of the deal with GE Healthcare at the end of July. Shareholders will be hoping that as the company starts to reap the rewards of the partnership, it will have a change in fortunes.

The Osprey share price is currently up 4.17%, however it remains more than 60% lower than its 52-week high of 6.3 cents. The Osprey share price is down 16.67% since the start of the year.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Analysts say these ASX shares are top buys in June

Brokers are urging investors to buy these shares. Let's find out why.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors finished the trading week on a high note this Friday.

Read more »

A man in trendy clothing sits on a bench in a shopping mall looking at his phone with interest and a surprised look on his face.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Brainchip, Findi, Lottery Corp, and REA shares are falling today

These shares are ending the week in the red. But why?

Read more »

Happy teen friends jumping in front of a wall.
Share Gainers

4 ASX 200 shares leading the charge higher this week

Investors have been piling into these four ASX 200 shares this week. But why?

Read more »

Woman and man calculating a dividend yield.
REITs

What price target does Macquarie have on Goodman Group shares?

Goodman Group posted an interesting set of numbers in Q3. Here's Macquarie's take.

Read more »

A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
Share Gainers

Why Catapult, Champion Iron, Healthco, and Meeka Metals shares are pushing higher today

These shares are ending the week on a high. But why?

Read more »

Miner looking at a tablet.
Broker Notes

Why Macquarie expects this ASX 200 copper stock to surge 36% in a year

Macquarie forecasts some hefty gains ahead for the ASX 200 copper miner. But why?

Read more »